Erythropoietin in Chronic kidney diseases
Erythropoietin (EPO) is a glycoprotein hormone used to treat anemia in chronic kidney disease (CKD). In CKD, the kidneys fail to produce adequate erythropoietin, leading to reduced red blood cell production. Erythropoiesis-stimulating agents (ESAs), synthetic versions of erythropoietin, help address this deficiency. Uses in CKD Safety Considerations ESAs are effective but require cautious use to […]